dacarbazine and etoposide

dacarbazine has been researched along with etoposide in 289 studies

Research

Studies (289)

TimeframeStudies, this research(%)All Research%
pre-199015 (5.19)18.7374
1990's31 (10.73)18.2507
2000's85 (29.41)29.6817
2010's136 (47.06)24.3611
2020's22 (7.61)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brunner, KW; Cavalli, F1
Cavalli, F1
Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U2
Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF1
Weiss, RB1
Bosly, A; Doyen, C; Ferrant, A; Machiels, JP; Martiat, P; Michaux, JL1
Gray, RG; Rees, JK1
Chang, SC; Hsu, JR; Perng, RP1
Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S1
Bastion, Y; Coiffier, B; Tigaud, JD1
Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S2
Bonadonna, G; Santoro, A; Valagussa, P1
DeVita, VT1
Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K1
Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD1
Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G1
Bladé, J; Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C1
Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN1
Engelhardt, R1
Ogawa, M1
Dimitriadis, K; Schmidt, CG; Schütte, J; Seeber, S1
Dalal, BI; Heyman, M; Horsman, D; Kidd, P; Kingreen, D; Loughran, TP; Phillips, GL1
Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G1
Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R1
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ1
Bloom, SR; Hammond, PJ1
Fukunishi, H; Kitazawa, S; Takeuchi, S; Yukimura, N1
Adkins, DR; Boldt, D; Freytes, CO; Irvin, R; Kuhn, J; LeMaistre, CF; Lyons, R; Roodman, GD; Salzman, D; Smith, L1
Asko-Seljavaara, S; Franssila, K; Kangas, L; Laasonen, A; Muhonen, T; Pyrhönen, S; Wasenius, VM1
Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H1
Berman, M; Blessing, JA; Burke, TW; Currie, J; Fowler, J; Muss, HB1
Berman, M; Blessing, JA; Currie, JL; McGehee, R; Soper, JT1
Anderson, PM; Skubitz, KM1
Guichard, M; Lartigau, E1
Abdallah, JM; Kirsch, IR; Lombardi, DP1
Cooper, DL; Levy, A; Salloum, E; Tallini, G1
Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S1
Egorova, NI; Garin, AM; Gorozhanskaia, EG; Koroleva, EIu; Kushlinskiĭ, NE; Larionova, VB1
Benincasa, E; Bonmassar, E; D'Atri, S; Graziani, G; Jiricny, J; Lacal, PM; Pagani, E; Tentori, L; Zambruno, G1
Bischoff, H; Diehl, V; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rueffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G1
Shimoyama, M; Tsushita, K; Utsumi, M1
Bischoff, H; Diehl, V; Dühmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rüffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G1
Foss, HD; Keilholz, U; Knauf, W; Siehl, J; Szelényi, H; Thiel, E1
Kim, CJ; Kushima, R; Okada, Y; Seto, A1
Bertrand, Y; Coze, C; Donadieu, J; Habrand, JL; Landman-Parker, J; Leblanc, T; Lemerle, J; Leverger, G; Oberlin, O; Pacquement, H; Perel, Y; Robert, A; Schaison, G; Terrier-Lacombe, MJ; Thuret, I1
Mitry, E; Rougier, P1
Berthold, F; Gahr, M; Hero, B; Hunneman, DH1
Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J1
D'Orazio, AI1
Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K1
Anselmo, AP; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Greil, R; Hasenclever, D; Herrmann, R; Josting, A; Kirchner, H; Koch, P; Koch, T; Lathan, B; Loeffler, M; Munker, R; Paulus, U; Pfistner, B; Pfreundschuh, M; Rueffer, U; Schalk, KP; Sieber, M; Tesch, H; Wolf, J1
Mori, R; Sano, T; Sinotou, K; Takigawa, H; Tatara, K; Taue, R; Uno, S1
Newton, HB; Santi, M; Stevens, C1
Carde, P; Cavalli, F; Diehl, V; Franklin, J1
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K1
Lichtman, SM; Skirvin, JA1
Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Linfomi, MB; Luminari, S; Santini, G1
Hutchinson, RJ; Kelly, KM; Lones, MA; Massey, V; Perkins, SL; Sposto, R; Weiner, MA1
Bökönyi, G; Horváth, A; Kéri, G; Szende, B1
del Palacio, A; Garau, M; Molina, L; Relaño, MT1
Ebert, BL; Niemierko, E; Salgia, R; Shaffer, K1
Starkhammar, H; Wall, N1
Benita-Weiss, M; Bushunow, P; Coyle, TE; Evans, B; Friedman, H; Korones, DN; Mechtler, L; Quinn, JA; Reardon, DA1
Diehl, V; Dörken, B; Dühmke, E; Franklin, J; Hasenclever, D; Herrmann, R; Lathan, B; Loeffler, M; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Tesch, H1
Ekert, H1
Kéri, G; Szende, B1
Hashimoto, H; Inada, F; Ishida, H; Kaneko, S; Kita, M; Okuyama, M; Saga, Y; Sasaki, Y; Tokumitsu, M; Yachiku, S1
Hehn, ST; Miller, TP1
Bischof, H; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Fischer, R; Georgii, A; Glunz, A; Greil, R; Hansmann, ML; Hasenclever, D; Hermann, R; Koch, B; Koch, P; Loeffler, M; Mueller, RP; Munker, R; Oertel, J; Paulus, U; Pfistner, B; Roller, S; Rueffer, U; Schalk, KP; Schober, T; Sieber, M; Stein, H; Tesch, H; von Kalle, K; Willich, N; Worst, P1
Diehl, V; Eich, HT; Engert, A; Franklin, J; Gossmann, A; Hansemann, K; Josting, A; Kocher, M; Krug, B; Müller, RP; Semrau, R; Skripnitchenko, R; Staar, S1
Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M1
Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F1
Castellano, A; Cozza, R; De Laurentis, C; De Sio, L; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P; Ilari, I; Inserra, A; Jenkner, A; Milano, GM1
Abrams, J; Al-Katib, A; Ibrahim, D; Karanes, C; Lai, P; Millenson, M; Pemberton, P; Smith, MR; Varterasian, M; Yeslow, G1
Ballova, V; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Haverkamp, H; Hentrich, M; Josting, A; Löffler, M; Müller-Hermelink, HK; Naumann, R; Pfistner, B; Rüffer, JU; Wilhelmy, M; Worst, P1
Boettcher, HD; Diehl, V; Eich, HT; Engert, A; Franklin, J; Glossmann, JP; Josting, A; Müller, RP; Nogová, L; Schober, T; Schulz, U; Sieber, M1
Illés, A; Molnár, Z; Udvardy, M1
Connors, JM3
Bouffet, E; Foreman, N; Korones, DN; Smith, A1
Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U1
Behringer, K; Breuer, K; Diehl, V; Engert, A; Klimm, B; May, M; Nogova, L; Reineke, T; Schmitz, T; Wildt, L1
Bartlett, NL2
Clawson, S; Cullen, MH; Hancock, BW; Jack, AS; Johnson, PW; MacLennan, KA; Radford, JA; Ryder, D; Smith, P; Stenning, SP; Sydes, MR; Walewski, J1
Addo-Yobo, SO; Donson, AM; Foreman, NK; Gore, L; Handler, MH1
Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ1
Elbl, L; Jedlicka, F; Kral, Z; Smardova, L; Tomaskova, I; Vasova, I; Vorlicek, J; Wagnerova, B1
Bajciova, V; Kadlecova, V; Kepak, T; Mazanek, P; Mudry, P; Pavelka, Z; Sterba, J; Valik, D; Zitterbart, K1
Gospodarowicz, MK; Heaton, R; Hodgson, DC; Koh, ES; Pintilie, M; Sun, A; Tran, TH; Tsang, R; Wells, W1
Berger, MS; Katayama, M; Kawaguchi, T; Pieper, RO1
Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M1
Fangusaro, J; Finlay, J; Rook, J; Rosser, T1
Aoki, S; Hirano, M; Miura, I; Niitsu, N; Okamoto, M; Tamaru, J; Tomita, N1
Chen, ZP; Mu, YG; Sai, K; Shi, HL; Yue, WY; Zhang, JP; Zhang, XH1
Datsenko, PV; Kharchenko, VP; Mel'nik, IuD; Panyshin, GA; Sotnikov, VM1
Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L1
Al-Ali, HK; Niederwieser, D; Wittekind, C1
Diehl, V; Fuchs, M1
Aird, EG; Diez, P; Hoskin, PJ1
Horning, SJ1
Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M1
Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G1
Wedgwood, A; Younes, A1
Barada, WM; Bazarbachi, A; Beydoun, A; Hourani, R; Masroujeh, R; Otrock, ZK1
Filatova, LV2
Behringer, K; Diehl, V; Engert, A; Fuchs, M; Halbsguth, T; Josting, A; Nogova, L; Reineke, T; Sieniawski, M1
Ashley, DM; Dobrovic, A; Drummond, KJ; Friedman, HS; Gan, HK; Hawkins, CJ; Johns, TG; Kaye, AH; Lovric, MM; Maxwell, JA; Mikeska, T; Riffkin, CD1
Diehl, V; Evens, AM; Hutchings, M1
Brice, P; Casasnovas, O; Cazeneuve, C; Gabarre, J; Koscielny, S; Lenoir, G; Morschhauser, F; Ribrag, V; Salles, G; Stamatoullas, A1
Bourgeois, JM; Hodson, I; Macdonald, P; Midia, M; Mullah-Ali, A; Portwine, C; Ramsay, JA1
Andrieu, JM; Arakelyan, N; Berthou, C; Colonna, P; de Guibert, S; Delwail, V; Desablens, B; Jais, JP; Moles, MP; Quittet, P1
Angrilli, F; Baldini, L; Brugiatelli, M; Cervetti, G; Di Renzo, N; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Luminari, S; Marcheselli, L; Mazza, P; Merli, F; Montanini, A; Musto, P; Polimeno, G; Pozzi, S; Scalone, R; Stelitano, C1
Fujii, M; Ito, M; Natsume, A; Ohno, M; Wakabayashi, T1
Brugiatelli, M; Danova, M; Federico, M; Gentile, M; Gobbi, PG; Iannitto, E; Luminari, S; Mammi, C; Merli, F; Morabito, F; Quintana, G; Rovati, B; Stelitano, C; Valentino, F1
Darzynkiewicz, Z; Kurose, A; Ogasawara, K; Ogawa, A; Sato, Y; Sawai, T; Traganos, F1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S1
Fukushima, T; Inoue, T; Komatsu, F; Ohmura, T; Ohta, M; Oshiro, S; Sakamoto, S; Tsugu, H1
Avigdor, A; Ben-Bassat, I; Bulvik, S; Dann, EJ; Levi, I; Nagler, A; Perez-Avraham, G; Polliack, A; Shemtov, N; Shimoni, A1
Aulitzky, WE; Bentz, M; Diehl, V; Dörken, B; Engert, A; Franklin, J; Hänel, M; Hasenclever, D; Koch, P; Löffler, M; Lohri, A; Ludwig, WD; Müller-Hermelink, HK; Pfreundschuh, M; Rummel, M; Sezer, O; Trümper, L; Wilhelm, M1
Pappo, A; Paulino, AC1
Abe, K; Furuhashi, S; Maebayashi, T; Sakaguchi, M; Shizukuishi, T; Sugitani, M; Takahashi, M; Tanaka, Y; Uematsu, A1
Bleyer, A; Choi, M; Fuller, CD; Raney, RB; Wang, SJ1
García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L1
Bonetti, E; Dondi, A; Falorio, S; Federico, M; Gobbi, PG; Merli, F; Quarta, G; Rosti, V; Stelitano, C; Valentino, F1
Kuruvilla, J1
Feng, C; Liu, Y; Tang, SQ; Wang, JW; Yang, G1
Cheson, BD2
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Pastore, M; Riccardi, R; Rizzo, D; Ruggiero, A1
Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N1
Bergsträsser, E; Dieckmann, K; Dörffel, W; Fosså, A; Hasenclever, D; Hummel, M; Karlén, J; Klapper, W; Kluge, R; Körholz, D; Mann, G; Mauz-Körholz, C; Pelz, T; Ruschke, K; Stein, H; Stiefel, M; Vilser, C; Voigt, A; Vordermark, D; Winkler, M1
Lampka, E; Sagan, D; Semczuk, A1
Borchmann, P; Debus, J; Diehl, V; Döhner, H; Dörken, B; Eich, HT; Engert, A; Görgen, H; Greil, R; Grosu, AL; Ho, A; Karstens, JH; Markova, J; Müller, RP; Müller-Hermelink, HK; Pabst, T; Rank, A; Schmidberger, H; Wiegel, T; Willich, N1
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M1
Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Eghbali, H; Foussard, C; Gressin, R; Jaubert, J; Lamy, T; le Gouill, S; Lucas, V; Maloisel, F; Milpied, N; Peoch, M; Rossi, JF; Simon, A; Thyss, A; Tournilhac, O; Vilque, JP1
Cawkwell, L; Little, SJ; Maraveyas, A; Murray, A; Stanley, P1
Desjardins, A; Friedman, AH; Friedman, HS; Gururangan, S; Herndon, JE; Marcello, J; McLendon, R; Peters, K; Reardon, DA; Rich, JN; Sampson, J; Threatt, S; Vredenburgh, JJ1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S1
Bozhenko, VK; Datsenko, PV; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM1
Barrington, S; Biggi, A; Cantonetti, M; Chauvie, S; Di Raimondo, F; Fallanca, F; Feldman, T; Ficola, U; Fiore, F; Gallamini, A; Gavarotti, P; Gianni, AM; Leone, M; Mulè, A; Patti, C; Rambaldi, A; Rossi, A; Sorasio, R; Stelitano, C; Viviani, S1
Anson, J; Gollard, RP; Khoury, J; Mason, J; Rosen, L1
Al Nawakil, C; Beranger, N; Brice, P; Brière, J; de Bazelaire, C; de Kerviler, E; Ertault, M; Franchi, P; Sibon, D; Thieblemont, C1
Busch, C; Knappskog, S; Oberg, K; Sebjornsen, S; Sorbye, H; Welin, S1
Bangert, A; Cristofanon, S; Debatin, KM; Fulda, S; Häcker, S1
Bay, JO; Blay, JY; Bonichon, F; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Italiano, A; Jimenez, M; Lotz, JP; Mathoulin-Pélissier, S; Penel, N; Ray-Coquard, I; Thyss, A1
Straus, DJ1
Bonadonna, G; Bonfante, V; Brusamolino, E; Gallamini, A; Gianni, AM; Gotti, M; Levis, A; Liberati, AM; Pogliani, EM; Pregno, P; Pulsoni, A; Rambaldi, A; Rossi, A; Rota Scalabrini, D; Specchia, G; Valagussa, P; Vitolo, U; Viviani, S; Zaja, F; Zinzani, PL1
Boström, J; Glas, M; Herrlinger, U; Kim, Y; Mack, F; Rieger, J; Schäfer, N; Scheffler, B; Simon, M; Steinbach, JP; Stuplich, M; Thanendrarajan, S; Tichy, J1
Bauer, K; Brillant, C; Engert, A; Monsef, I; Skoetz, N1
Johnson, PW; Lim, SH1
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT1
Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T1
Borchmann, P; Diehl, V; Engert, A1
Craig, EA; Spiegelman, VS1
Chen, YH; Dosoretz, AP; Fisher, DC; Fox, AM; Freedman, AS; LaCasce, AS; Mauch, PM; Ng, AK; Silver, B1
Desjardins, A; Sampson, JH1
Behringer, K; Borchmann, P; Diehl, V; Eibl, AD; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Halbsguth, T; Kuehr, M; Mueller, H; Reiners, KS; Renno, JH; Rosenbrock, J; Thielen, I; van der Ven, K; von Wolff, M1
Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ1
Borchmann, P; Diehl, V; Eich, HT; Engert, A; Fuchs, M; Greil, R; Klimm, B; Kral, Z; Lohri, A; Markova, J; Meissner, J; Mueller, RP; Plütschow, A; Soekler, M; Stein, H; Topp, MS; von Tresckow, B; Zijlstra, JM1
André, N; Bajciova, V; Deak, L; Demlova, R; Doubek, M; Dubska, L; Husek, K; Kepak, T; Kutnikova, L; Kyr, M; Martincekova, A; Mazanek, P; Mudry, P; Pavelka, Z; Skotakova, J; Sterba, J; Valik, D; Zapletalova, D; Zitterbart, K1
Kuruvilla, J; Uhm, J1
Ballanti, S; Dammacco, F; Di Ianni, M; Falzetti, F; Iodice, G; Martelli, MF; Minelli, O; Reale, A; Ria, R; Serio, G; Vacca, A1
Aznar Oroval, E; García-Lozano, T; Juan Bañón, JL; Lorente Alegre, P1
Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM3
Filatova, LV; Gershanovich, ML; Semiglazova, TIu; Tarasenkova, AA1
Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ1
Filatova, LV; Gershanovich, ML; Semiglazov, TIu; Tarasenkova, AA1
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N1
Hwang, W; Lee, YS; Phipps, C1
Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N1
Bisogno, G; Carli, M; Casanova, M; Dall'Igna, P; De Ioris, MA; De Leonardis, F; De Salvo, GL; Ferrari, A; Manzitti, C; Meazza, C1
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C1
Alt, J; Arasteh, K; Berger, M; Engert, A; Fätkenheuer, G; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Nickelsen, M; Planker, M; Rieke, A; Rockstroh, JK; Schmidmaier, R; Schürmann, D; Seidel, E; Siehl, J; Wolf, T; Wyen, C1
Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS1
Behringer, K; Borchmann, P; Diehl, V; Eibl, AD; Engert, A; Fuchs, M; Goergen, H; Halbsguth, T; Kuehr, M; Mueller, H; Reiners, KS; Renno, JH; Rosenbrock, J; Schober, T; Stumpf, V; Thielen, I; van der Ven, K; von Wolff, M; Wessels, C; Wiehlpütz, M1
Anderluh, G; Assunção, Fdos S; Biasoli, D; de Souza, JM; Frauches, AC; Garcia, C; Geraldo, LH; Kahn, SA; Lima, FR; Moura-Neto, V; Pontes, B; Romão, L; Sobrinho, M; Soletti, RC; Tovar-Moll, F1
Advani, R; Bartlett, NL; Blum, KA; Cheson, BD; Connors, JM; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Stiff, PJ; Tuscano, JM; Wagner, H1
Advani, R; Bartlett, NL; Cheson, BD; Connors, JM; Evens, AM; Fisher, RI; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Miller, TP; Stiff, PJ; Wagner, H1
Advani, R; Ambinder, RF; Bartlett, NL; Cheson, BD; Fisher, RI; Gascoyne, RD; Gellert, LL; Gordon, LI; Hong, F; Horning, SJ; Hsieh, WS; Kahl, BS; Kanakry, JA; Lemas, MV; Li, H; Miller, TP; Stiff, P; Tan, KL1
Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kumar, A; Schöder, H; Vargas, HA; Zelenetz, AD1
Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG1
Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E1
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Riccardi, R; Ridola, V; Rizzo, D; Ruggiero, A1
Borchmann, P; Kreissl, S1
Aulitzky, W; Borchmann, P; Diehl, V; Dührsen, U; Engert, A; Fuchs, M; Hertenstein, B; Klimm, B; Lindemann, W; Maschmeyer, G; Plütschow, A; Sasse, S; Vieler, T; Wongso, D1
Filatova, LV; Gershanovich, ML; Plotnikova, AA; Semiglazova, TIu1
Borchmann, P; Diehl, V; Engert, A; Haverkamp, H; Rancea, M; Skoetz, N; Trelle, S1
Cao, H; Weber, R; Yamamoto, K; Yang, LX1
Arakawa, Y; Fujimoto, K; Kikuchi, T; Kunieda, T; Miyamoto, S; Mizowaki, T; Murata, D; Takagi, Y; Takahashi, JC1
Cella, L; Conson, M; D'Avino, V; Di Biase, A; Liuzzi, R; Pacelli, R; Picardi, M; Pugliese, N; Salvatore, M; Solla, R1
Borchmann, P1
Ansell, SM1
Canellos, GP; Devita, VT; Friedberg, JW; Lister, TA; Rosenberg, SA1
Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M1
Abruzzese, E; André, MP; Bardet, S; Bellei, M; Bouabdallah, R; Brice, P; Brusamolino, E; Casasnovas, RO; Federico, M; Fermé, C; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Lievens, Y; Lugtenburg, PJ; Meignan, M; Morschhauser, F; Olivier, P; Oumedaly, R; Raemaekers, JM; Raveloarivahy, T; Re, A; Sebban, CJ; Stamatoullas, A; van der Borght, T; van der Maazen, R; van Imhoff, G; Versari, A1
Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A1
Andre, M; Aoudjhane, A; Bachy, E; Bologna, S; Brice, P; Briere, J; Carde, P; Casasnovas, O; Colin, P; Delmer, A; Devidas, A; Gabarre, J; Gaillard, I; Heczko, M; Humbrecht, C; Jaubert, J; Mounier, N; Nicolas-Virelizier, E1
Amatulli, M; Balderes, P; Brennan, L; Burtrum, D; Credille, KM; Damoci, CB; DeLigio, JT; Duignan, IJ; Kotanides, H; Lebron, MB; Loizos, N; O'Mahony, M; Paz, K; Persaud, K; Prewett, MC; Schwartz, KD; Starodubtseva, M; Surguladze, D; Zhang, Y1
Cesano, A; Conroy, A; Cordeiro, JA; Fields, SZ; Hawtin, RE; Leung, LY; Louie, B; Rosen, DB; Shapira, I1
Bates, A; Cooke, R; Cunningham, D; Falk, SJ; Gilson, D; Hancock, BW; Harris, SJ; Horwich, A; Hoskin, PJ; Linch, DC; Lister, A; Lucraft, HH; Radford, J; Stevens, AM; Swerdlow, AJ; Syndikus, I; Williams, MV1
Nagai, H1
Escalon, E; Lollett, IV; Melnick, SJ; Quirin, KW; Ramachandran, C1
Baudin, E; Caplin, ME; Ferolla, P; Filosso, P; Garcia-Yuste, M; Lim, E; Oberg, K; Pelosi, G; Perren, A; Rossi, RE; Travis, WD1
Ganesan, P; Ganesan, TS; Kannan, K; Krishnakumar, R; Lakshmipathy, KM; Mahajan, V; Radhakrishnan, V; Rajaraman, S; Rajendranath, R; Sagar, TG; Sundersingh, S; Udupa, K1
Chang, FC; Chang, KP; Chen, HH; Chen, YW; Guo, WY; Ho, DM; Hu, YW; Lai, IC; Lee, YY; Liang, ML; Shiau, CY; Wong, TT; Yen, SH1
Elhag, R; Mazzio, EA; Soliman, KF1
Advani, RH; Bartlett, NL; Blum, KA; Cheson, BD; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Robinson, KS; Stewart, DA; Stiff, PJ; Tuscano, JM; Wagner, H1
Gallamini, A; Kostakoglu, L1
Datsenko, PV; Panshin, GA1
Advani, RH; Bartlett, NL; Blum, KA; Cheson, BD; Crump, M; Diefenbach, CS; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Li, H; Stewart, DA; Stiff, PJ; Tuscano, JM; Wagner, H1
Golubeva, OV; Gorovtsova, OV; Gorshkov, IM; Krivovyaz, OS; Polyakov, VG; Ushakova, TL; Yarovoy, AA1
Engert, F; Fulda, S; Probst, M; Schneider, C; Weiβ, LM1
Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A1
Boltežar, L; Jezeršek Novaković, B; Pintarić, K1
Annechini, G; Fiore, G; Gandini, L; Lenzi, A; Lombardo, F; Pallotti, F; Paoli, D; Pulsoni, A; Rizzo, F1
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C1
Arakelyan, S; Avagyan, A; Bardakchyan, S; Danielyan, S; Hakobyan, L; Harutyunyan, L; Iskanyan, S; Safaryan, L; Sargsyan, L; Tamamyan, G; Voskanyan, A; Zohrabyan, D1
Barr, PM; Bartlett, NL; Cheson, BD; Cook, JR; Evens, AM; Fanale, MA; Fisher, RI; Friedberg, JW; Gascoyne, RD; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Lechowicz, MJ; Leonard, JP; Li, H; Mittra, ES; Moskowitz, CH; Noy, A; Press, OW; Rimsza, LM; Schöder, H; Straus, DJ; Sweetenham, JW1
Aurer, I; Bologna, S; Brice, P; Caillot, D; Carde, P; Casasnovas, O; Coiffier, B; Ferme, C; Fortpied, C; Gaillard, I; Glimelius, B; Karrasch, M; Khaled, H; Lugtenburg, PJ; Meyer, R; Morschhauser, F; Mounier, N; Seftel, M; Sureda, A; Wolf, M1
Kondo, T; Miyamoto, M; Ohta, T; Watanabe, T; Yamamoto, Y; Yamasaki, H1
de Stanchina, E; Desmeules, P; Gardner, EE; Lok, BH; Ni, A; Poirier, JT; Powell, SN; Rekhtman, N; Riaz, N; Rudin, CM; Schneeberger, VE; Teicher, BA1
Borchmann, S; Engert, A; von Tresckow, B1
Johnson, PWM; Vassilakopoulos, TP1
Chen, G; Chen, Y; Huang, R; Jiang, Y1
Kobos, R; LaQuaglia, MP; Modak, S; Pandit-Taskar, N; Sait, S1
Johnson, PW1
Cheson, BD; Kostakoglu, L1
Ceylan, S; Gokturk, D; Kelebek, H; Yilmaz, DM1
Bouaouina, N; Fourati, N; Kanoun Belajouza, S; Khlif, A; Regaieg, H1
André, MPE; Bellei, M; Bouabdallah, R; Brice, P; Casasnovas, O; Delarue, R; Edeline, V; Federico, M; Fermé, C; Fiaccadori, V; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Meignan, M; Merli, F; Raemaekers, J; Raveloarivahy, T; Re, A; Reman, O; Sebban, C; Specht, L; Stamatoullas, A; van der Maazen, R; van Imhoff, G; Versari, A1
Borchmann, P; Borchmann, S; Bröckelmann, PJ; Buerkle, C; Diehl, V; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Müller, H; Plütschow, A; Sasse, S1
Brillant, C; Engert, A; Monsef, I; Skoetz, N; von Tresckow, B; Will, A1
Abadi, U; Abdah-Bortnyak, R; Akria, L; Bairey, O; Bar-Shalom, R; Barzilai, E; Ben-Yehuda, D; Dann, EJ; Epelbaum, R; Filanovsky, K; Goldschmidt, N; Horowitz, NA; Kagna, O; Kornberg, A; Lavie, D; Mashiach, T; Paltiel, O; Ruchlemer, R; Shpilberg, O; Tadmor, T1
Anglaret, B; Audhuy, B; Bologna, S; Bouabdallah, R; Brice, P; Brière, J; Carde, P; Casasnovas, O; de Jong, D; de Weerdt, O; Delarue, R; Eghbali, H; Fermé, C; Henry-Amar, M; Janvier, M; Lugtenburg, PJ; Lybeert, MLM; Marjanovic, Z; Noordijk, EM; Raemaekers, JMM; Reman, O; Salles, G; Sebban, C; Spina, M; Tersteeg, RJHA; Thomas, J; Thyss, A; van Imhoff, GW; Vranovsky, A1
Advani, RH; Bartlett, NL; Chen, L; Connors, JM; Constine, LS; Evens, AM; Friedberg, JW; Friedman, DL; Gascoyne, RD; Gordon, LI; Henderson, TO; Hong, F; Horning, S; Kahl, BS; Kelly, KM; Leonard, JI; Li, H; McNeer, JL; Parsons, SK; Schwartz, CL; Shah, B; Smith, SM; Wroblewski, KE1
Bison, B; Bojko, S; Gielen, GH; Hoffmann, M; Kortmann, RD; Kramm, CM; Pietsch, T; Seidel, C; von Bueren, AO; Warmuth-Metz, M1
Billett, AL; LaCasce, AS; Marcus, KJ; Ozuah, NW1
Avigdor, A; Battistini, R; Bergesio, F; Biggi, A; Billio, A; Bolis, S; Cantonetti, M; Chauvie, S; Chiaravalloti, A; Cimminiello, M; Corradini, P; Fallanca, F; Ferreri, AJM; Ficola, U; Gallamini, A; Gavarotti, P; Gianni, AM; Gini, G; Gottardi, D; Gregianin, M; La Nasa, G; Miglino, M; Mulé, A; Parvis, G; Patti, C; Pavoni, C; Picardi, M; Prosperini, G; Rambaldi, A; Rapezzi, D; Romano, A; Rossi, A; Schiavotto, C; Tarella, C; Trentin, L; Viero, P; Viviani, S; Zanotti, R1
Akhtar, S; Elhassan, TAM; Elshenawy, MA; Maghfoor, I; Shahzad Rauf, M1
Ahmed, EM; Bandopadhyay, G; Coyle, B; Grabowska, A1
Bröckelmann, PJ; Engert, A; Sasse, S1
Andraos, TY; Aristophanous, M; Chuang, HH; Dabaja, BS; Fanale, MA; Gunther, JR; Hancock, D; Ludmir, EB; Mikhaeel, NG; Milgrom, SA; Nastoupil, L; Oki, Y; Pham, M; Pinnix, CC; Wirth, A1
Ito, M; Ito, R; Kageyama, Y; Katayama, N; Kawakami, K; Masuya, M; Nagaharu, K; Yamaguchi, T1
Baues, C; Behringer, K; Böll, B; Borchmann, P; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Greil, R; Markova, J; Meissner, J; Neubauer, A; Plütschow, A; Sasse, S; Topp, MS; von Tresckow, B; Zijlstra, JM1
Bartlett, NL; Chang, JE; Cheson, BD; Friedberg, JW; Grecula, JC; Hsi, ED; Jung, SH; Kahl, BS; Kostakoglu, L; Leonard, JP; Moskowitz, CH; Pitcher, B; Popplewell, LL; Schöder, H; Straus, DJ; Wagner-Johnston, N1
Barr, PM; Bartlett, NL; Evens, AM; Friedberg, JW; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Leonard, JP; Li, H; Moskowitz, CH; Rimsza, LM; Schöder, H; Smith, SM; Stephens, DM; Straus, DJ1
Asad, M; Mehreen, A; Ria, S; Sindhu, II; Wali, RM1
Anderson, NR; Collins, J; O'Bryen, J1
Farrugia, MK; Vargo, JA1
Chan, K; Cheung, MC; Prica, A; Vijenthira, A1
Brown, AM; Devata, S; Marini, BL; Nachar, VR; Perissinotti, AJ; Reid, JH1
Adouni, O; Bertucci, F; Birnbaum, D; Finetti, P; Gamoudi, A; Manai, M; Mezlini, A; Zawati, I1
Angelov, D; Cotter, AG; Fay, M; Lambert, JS; McGettrick, P; McGinty, T; O'Kelly, B; Sheehan, G1
Bohn, JP; Botto, B; Cavallo, F; Cerchione, C; Cuzzocrea, S; De Lorenzo, S; Dogliotti, I; Ferrero, S; Loseto, G; Martinelli, G; Mian, M; Mondello, P; Musolino, C; Nappi, D; Schmitt, C; Straus, DJ; Willenbacher, W; Wolf, D1
Advani, RH; Corbelli, KS; Daadi, SE; Hoppe, RT; Qian, Y; Rosenberg, SA; Von Eyben, R; Weil, CR1
Jin, Z; Wang, Y; Wang, Z; Wei, N1
André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL1
Ahmed, K; Amin, MSA; Brunckhorst, O; Gleeson, M; Kazmi, M; Scott, C; Wrench, D1
Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B1
Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F1
Collins, A; Cooke, L; Docherty, S; Follows, GA; Fowler, A; Grigoropoulos, N; Hodson, A; Johnson, P; Karanth, M; Kirkwood, AA; Lentell, I; Maw, K; Padayatty, J; Qian, W; Russell, J; Sadullah, S; Saha, C; Shah, N; Uttenthal, BJ1
Ashykhmin, A; Gorbach, O; Kadnikova, T; Karnabeda, O; Karpova, O; Kmetyuk, I; Kosinova, V; Kostiukova, N; Kozlov, V; Kriachok, I; Lukjanec, O; Mykhalska, L; Novikov, M; Novosad, O; Oliinichenko, O; Pastushenko, I; Skrypets, T; Stratienko, V1
Cui, F; Yan, J; Zhao, S1
Collins, GP; Cwynarski, K; Phillips, EH1
Arikoglu, T; Balci, Y; Citak, EC; Gundogan, BD; Taskinlar, S1
Ando, J; Ando, M; Komatsu, N; Yasuda, H1
Chen, Q; Ding, M; Dong, M; Ge, J; Hou, H; Kong, X; Lei, Y; Qian, S; Wang, W; Wang, Z; Wen, Q; Zhang, M; Zhang, X; Zhang, Y; Zhu, L1
Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S1
El-Galaly, TC; Eloranta, S; Entrop, JP; Fosså, A; Glimelius, I; Holte, H; Jakobsen, LH; Marklund, A; Molin, D; Smedby, KE; Smeland, KB; Weibull, CE; Øvlisen, AK1
Akrawikrai, T; Bunworasate, U; Chamnanchanunt, S; Iam-Arunthai, K; Nakhahes, C; Suwanban, T; Thungthong, P1

Reviews

44 review(s) available for dacarbazine and etoposide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[New substances in oncologic therapy].
    Schweizerische medizinische Wochenschrift, 1978, Aug-12, Volume: 108, Issue:32

    Topics: Alkylating Agents; Altretamine; Antimetabolites, Antineoplastic; Cisplatin; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Etoposide; Humans; Neoplasms; Nitrosourea Compounds; Razoxane; Tamoxifen; Vinca Alkaloids; Zinostatin

1978
Hypersensitivity reactions.
    Seminars in oncology, 1992, Volume: 19, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide

1992
[Treatment of relapses and failures in disseminated Hodgkin's disease].
    Presse medicale (Paris, France : 1983), 1991, Nov-02, Volume: 20, Issue:35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine

1991
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine

1996
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

1998
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

1998
Chemotherapy in the treatment of neuroendocrine malignant tumors.
    Digestion, 2000, Volume: 62 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Streptozocin

2000
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hodgkin Disease; Humans; Infertility; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Treatment Outcome; Vinblastine; Vincristine

2000
Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.
    Drugs & aging, 2002, Volume: 19, Issue:1

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Complementary Therapies; Cytochrome P-450 Enzyme System; Dacarbazine; Etoposide; Humans; Idarubicin; Neoplasms; Tamoxifen; Temozolomide; Thalidomide; Topotecan

2002
TT-232: a somatostatin structural derivative as a potent antitumor drug candidate.
    Anti-cancer drugs, 2003, Volume: 14, Issue:8

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dacarbazine; Etoposide; Humans; Neoplasms; Peptides, Cyclic; Somatostatin

2003
[Pulmonary rhabdomyosarcoma generated during treatment of testicular tumor].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2003, Volume: 94, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Embryonal; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Male; Orchiectomy; Pneumonectomy; Rhabdomyosarcoma; Seminoma; Testicular Neoplasms; Vincristine

2003
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Current hematology reports, 2004, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Forecasting; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Multicenter Studies as Topic; Pilot Projects; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2004
[Primary treatment of advanced Hodgkin's disease].
    Orvosi hetilap, 2005, Jan-30, Volume: 146, Issue:5

    Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Meta-Analysis as Topic; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Risk Factors; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine

2005
ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
    Clinical lymphoma, 2005, Volume: 6, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine

2005
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2007, Volume: 37, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine

2007
Risk, cure and complications in advanced hodgkin disease.
    Hematology. American Society of Hematology. Education Program, 2007

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Risk; Vinblastine; Vincristine

2007
Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
    Clinical lymphoma & myeloma, 2007, Volume: 8 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Prednisone; Procarbazine; Recombinant Proteins; Vinblastine; Vincristine

2007
Treatment of Hodgkin lymphoma: the past, present, and future.
    Nature clinical practice. Oncology, 2008, Volume: 5, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine

2008
Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 18; Chromosomes, Human, X; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Lumbar Vertebrae; Mechlorethamine; Muscle Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Remission Induction; Retroperitoneal Neoplasms; Sarcoma, Synovial; Spinal Stenosis; Translocation, Genetic; Vincristine

2008
Standard therapy of advanced Hodgkin lymphoma.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2009
Is BEACOPP better than ABVD?
    Current hematologic malignancy reports, 2007, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Forecasting; Hodgkin Disease; Humans; Infertility; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Patient Selection; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

2007
Chemotherapy only for localized Hodgkin lymphoma.
    Journal of internal medicine, 2011, Volume: 270, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fibrosis; Gemcitabine; Heart; Hodgkin Disease; Humans; Hypothyroidism; Lung; Lymphedema; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2011
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
    The Cochrane database of systematic reviews, 2011, Aug-10, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult

2011
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
    Blood reviews, 2012, Volume: 26, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Vinblastine; Vincristine

2012
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
    Journal of the National Cancer Institute, 2012, Jul-18, Volume: 104, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines

2012
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2013

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2013
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
    The Lancet. Oncology, 2013, Volume: 14, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine

2013
Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
    Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2014
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
    Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine

2014
[Treatment strategy of Hodgkin lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine

2014
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Dacarbazine; Etoposide; Europe; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Receptors, Somatostatin; Societies, Medical; Temozolomide; Tomography, X-Ray Computed; Ultrasonography

2015
Current developments in the treatment of early-stage classical Hodgkin lymphoma.
    Current opinion in oncology, 2016, Volume: 28, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2016
Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
    International journal of hematology, 2016, Volume: 104, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2016
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?
    Hematology. American Society of Hematology. Education Program, 2016, Dec-02, Volume: 2016, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glucose-6-Phosphate; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2016
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
    Oncology (Williston Park, N.Y.), 2017, 01-15, Volume: 31, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2017
[Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2017, Volume: 21, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; False Negative Reactions; Female; Hodgkin Disease; Humans; Infertility, Female; Low Back Pain; Magnetic Resonance Imaging; Organ Sparing Treatments; Osteomyelitis; Ovary; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Conformal; Remission Induction; Sacrum; Spinal Neoplasms; Vinblastine; Vincristine; Young Adult

2017
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
    The Cochrane database of systematic reviews, 2017, 05-25, Volume: 5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult

2017
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
    Blood, 2018, 04-12, Volume: 131, Issue:15

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Risk Assessment; Sex Factors; Survival Rate; Vinblastine; Vincristine

2018
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
    Journal of medical case reports, 2018, May-30, Volume: 12, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Brentuximab Vedotin; Carboplatin; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Immunoconjugates; Male; Vinblastine

2018
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
    Critical reviews in oncology/hematology, 2020, Volume: 148

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
    Cancer medicine, 2020, Volume: 9, Issue:18

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult

2020
ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fertility; Hodgkin Disease; Humans; Infertility, Male; Male; Prednisone; Procarbazine; Vinblastine; Vincristine

2021
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
    Clinical lymphoma, myeloma & leukemia, 2022, Volume: 22, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Mechlorethamine; Nivolumab; Prednisolone; Procarbazine; Renal Dialysis; Vinblastine; Vincristine; Vinorelbine

2022

Trials

80 trial(s) available for dacarbazine and etoposide

ArticleYear
[New substances in oncologic therapy].
    Deutsche medizinische Wochenschrift (1946), 1978, Jul-07, Volume: 103, Issue:27

    Topics: Altretamine; Ancitabine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cisplatin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Mitolactol; Nitrosourea Compounds; Razoxane; Remission, Spontaneous; Tamoxifen; Time Factors; Vinca Alkaloids; Zinostatin

1978
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
    Medizinische Klinik (Munich, Germany : 1983), 1992, Nov-15, Volume: 87, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine

1992
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
    Acta clinica Belgica, 1992, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mitoguazone; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vinblastine; Vincristine

1992
Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Drug Combinations; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Nimustine; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Thioguanine; United Kingdom; Vincristine

1990
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
    Annals of internal medicine, 1986, Volume: 104, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine

1986
[Intermediate results of the German Hodgkin's disease therapy study].
    Onkologie, 1986, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine

1986
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
    Onkologie, 1987, Volume: 10, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine

1987
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine

1994
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
    International journal of radiation oncology, biology, physics, 1994, Nov-15, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine

1994
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
    Blood, 1995, Jul-15, Volume: 86, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1995
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Hypotension; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Transplantation, Autologous

1994
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine

1995
Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 1996, Volume: 61, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etoposide; Female; Humans; Hydroxyurea; Leiomyosarcoma; Middle Aged; Survival Analysis; Treatment Outcome; Uterine Neoplasms

1996
Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
    Gynecologic oncology, 1996, Volume: 61, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease Progression; Etoposide; Female; Humans; Hydroxyurea; Middle Aged; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Neoplasms

1996
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
    The Journal of laboratory and clinical medicine, 1996, Volume: 127, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine

1996
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Czech Republic; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Switzerland; Treatment Outcome; Vinblastine; Vincristine

1998
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

1998
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Radiotherapy Dosage; Treatment Outcome; Vinblastine

2000
Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:1

    Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Homovanillic Acid; Humans; Ifosfamide; Iodine Radioisotopes; Life Tables; Melphalan; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vanilmandelic Acid; Vincristine; Vindesine

2001
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2002
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13 Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

2002
Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13 Suppl 1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2002
Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Cancer, 2003, Apr-15, Volume: 97, Issue:8

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Temozolomide; Treatment Outcome

2003
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine

2003
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine

2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
    Acta paediatrica (Oslo, Norway : 1992). Supplement, 2004, Volume: 93, Issue:445

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neuroblastoma; Palliative Care; Temozolomide; Topotecan; Treatment Outcome

2004
Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mitoxantrone; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis

2004
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:1

    Topics: Administration, Oral; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2005
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2005
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2005
Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot study.
    Onkologie, 2006, Volume: 29, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Child, Preschool; Dacarbazine; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms; Pilot Projects; Pyrazoles; Sulfonamides; Temozolomide; Treatment Outcome; Tretinoin

2006
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2006
[Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
    Voprosy onkologii, 2006, Volume: 52, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome; Vinblastine

2006
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
    The British journal of radiology, 2007, Volume: 80, Issue:958

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Quality Assurance, Health Care; United Kingdom; Vinblastine; Vincristine

2007
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
    Surgical neurology, 2008, Volume: 69, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome

2008
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine

2008
Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablativ
    Cancer, 2008, Dec-15, Volume: 113, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Methylprednisolone; Prednisone; Treatment Outcome; Vinblastine; Vincristine

2008
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Feb-10, Volume: 27, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

2009
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
    Oncology reports, 2009, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

2009
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2010
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-20, Volume: 27, Issue:27

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2009
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:16

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Dacarbazine; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Temozolomide; Treatment Outcome

2010
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-20, Volume: 28, Issue:27

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Procarbazine; Radiation Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2010
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
    British journal of haematology, 2010, Volume: 151, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2010
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Etoposide; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide

2011
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
    British journal of haematology, 2011, Volume: 152, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Substitution; Epidemiologic Methods; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine

2011
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
    British journal of haematology, 2011, Volume: 153, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vinblastine

2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult

2012
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
    The New England journal of medicine, 2011, Jul-21, Volume: 365, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Remission Induction; Salvage Therapy; Vinblastine; Vincristine; Young Adult

2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2012
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Feb-15, Volume: 18, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome

2012
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-20, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2012
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
    Blood reviews, 2012, Volume: 26, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Vinblastine; Vincristine

2012
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma.
    Hematology (Amsterdam, Netherlands), 2012, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Middle Aged; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult

2012
Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
    British journal of haematology, 2012, Volume: 159, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Risk Assessment; Vinblastine; Vincristine

2012
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-20, Volume: 30, Issue:33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2012
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2013
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
    British journal of haematology, 2013, Volume: 161, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Blood, 2013, May-02, Volume: 121, Issue:18

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoadjuvant Therapy; North America; Prednisone; Prognosis; Sensitivity and Specificity; Vinblastine; Vincristine; Young Adult

2013
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors.
    Journal of neuro-oncology, 2013, Volume: 113, Issue:3

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Temozolomide

2013
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Aug-01, Volume: 31, Issue:22

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Mass Index; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Vinblastine; Vincristine

2013
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Apr-20, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine; Young Adult

2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2014
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2015
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jun-10, Volume: 33, Issue:17

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; North America; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2015
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 06-10, Volume: 34, Issue:17

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Vinblastine; Vincristine; Young Adult

2016
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 06-10, Volume: 34, Issue:17

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Medication Adherence; Middle Aged; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine

2016
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jun-01, Volume: 35, Issue:16

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Young Adult

2017
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jun-20, Volume: 35, Issue:18

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Vinblastine; Vincristine; Young Adult

2017
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
    British journal of haematology, 2017, Volume: 178, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Vinblastine; Vincristine; Young Adult

2017
ABVD or BEACOPP
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 81

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Risk Factors; Survival Analysis; Vinblastine; Vincristine; Young Adult

2017
Excellent Outcomes Following Response-based Omission of Radiotherapy in Children and Adolescents With Intermediate or High-risk Hodgkin Lymphoma.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Prednisolone; Retrospective Studies; Risk Factors; Vinblastine; Vincristine

2018
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Tria
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 02-10, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prospective Studies; Radiotherapy; Rituximab; Survival Analysis; Vinblastine; Vincristine; Young Adult

2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 09-01, Volume: 36, Issue:25

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Prednisone; Procarbazine; Progression-Free Survival; Treatment Outcome; Vincristine; Young Adult

2018
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
    Blood, 2018, 09-06, Volume: 132, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine

2018
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
    Blood, 2019, 10-10, Volume: 134, Issue:15

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult

2019
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
    The Lancet. Haematology, 2020, Volume: 7, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cost-Benefit Analysis; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
    American journal of hematology, 2020, Volume: 95, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine

2020
A Ukrainian multicenter prospective study of the value of PET/ CT prognostic role in primary patients with Hodgkins lymphoma in a real-life cohort.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2020,Winter, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Ukraine; Vinblastine; Vincristine; Young Adult

2020

Other Studies

167 other study(ies) available for dacarbazine and etoposide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine

1992
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
    Chest, 1990, Volume: 98, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine

1990
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine

1990
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Seminars in oncology, 1986, Volume: 13, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine

1986
Hematologic malignancies: non-Hodgkin's lymphomas.
    Hospital practice (Office ed.), 1986, Sep-15, Volume: 21, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vinblastine; Vincristine

1986
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine

1987
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Italy; Lomustine; Male; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine

1988
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
    Sangre, 1988, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine

1988
Allogeneic marrow transplantation for refractory Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine

1989
Third-line salvage chemotherapy in Hodgkin's disease.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine

1985
Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1988, Volume: 107

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Evaluation Studies as Topic; Female; Humans; Hyperthermia, Induced; Lung Neoplasms; Male; Melanoma; Vincristine; Vindesine

1988
[Research project of cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:3 Pt 2

    Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Cisplatin; Dacarbazine; Etoposide; Humans; International Cooperation; Japan; Neoplasms; Research; Thioguanine; United States

1985
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
    Cancer treatment reviews, 1984, Volume: 11 Suppl A

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Cell Line; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Humans; Ifosfamide; Male; Naphthacenes; Sarcoma; Teratoma; Testicular Neoplasms; Vinca Alkaloids; Vincristine

1984
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
    American journal of hematology, 1995, Volume: 50, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Killer Cells, Natural; Lymphocytes; Lymphocytosis; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; T-Lymphocytes; Vinblastine; Vincristine

1995
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine

1994
Gut neuroendocrine tumors.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Diazoxide; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferon-alpha; Neuroendocrine Tumors; Octreotide; Omeprazole; Pancreatic Neoplasms; Streptozocin

1994
Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1994, Volume: 46, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Etoposide; Fatal Outcome; Female; Humans; Hysterectomy; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Mitotic Index; Treatment Outcome; Uterine Neoplasms; Vincristine

1994
Mouse subrenal capsule assay chemosensitivity and DNA flow cytometry parameters of human melanoma metastases.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:4

    Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; DNA, Neoplasm; Etoposide; Female; Flow Cytometry; Humans; Male; Melanoma; Mice; Middle Aged; Subrenal Capsule Assay; Vincristine

1994
The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
    British journal of cancer, 1996, Volume: 73, Issue:12

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Melanoma; Mice; Mice, Nude; Rectal Neoplasms; Tirapazamine; Transplantation, Heterologous; Triazines

1996
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Time Factors; Vinblastine; Vincristine

1995
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
    British journal of cancer, 1998, Volume: 77, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine

1998
[The role of glutathione and glutathione-S-transferase in neoplasm drug resistance].
    Biulleten' eksperimental'noi biologii i meditsiny, 1998, Volume: 125, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Erythrocytes; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Male; Melanoma; Ovarian Neoplasms; Propionates; Skin Neoplasms; Testicular Neoplasms

1998
Involvement of the mismatch repair system in temozolomide-induced apoptosis.
    Molecular pharmacology, 1998, Volume: 54, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dacarbazine; DNA Repair; Etoposide; Humans; Nucleic Acid Heteroduplexes; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1998
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Immunization, Passive; Interleukin-2; Male; Melphalan; Middle Aged; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine

1999
Establishment and characterization of a prostatic small-cell carcinoma cell line (PSK-1) derived from a patient with Klinefelter syndrome.
    The Prostate, 2000, Mar-01, Volume: 42, Issue:4

    Topics: Adult; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Cisplatin; Dacarbazine; Doxorubicin; Etoposide; Fluorouracil; Humans; Karyotyping; Klinefelter Syndrome; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phosphopyruvate Hydratase; Prostatic Neoplasms; Tumor Cells, Cultured

2000
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Prednisone; Procarbazine; Radiotherapy; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
    Blood, 2001, Nov-15, Volume: 98, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine

2001
37th Annual American Society of Clinical Oncology Meeting. San Francisco, CA. May 12-15, 2001.
    Clinical lymphoma, 2001, Volume: 2, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Adhesion Molecules; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunosuppressive Agents; Immunotoxins; Lectins; Leukemia, Hairy Cell; Lymphoma, Non-Hodgkin; Multiple Myeloma; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Thalidomide; Vinblastine

2001
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine

2001
A case of pelvic malignant paraganglioma.
    International journal of urology : official journal of the Japanese Urological Association, 2001, Volume: 8, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pelvic Neoplasms; Radionuclide Imaging; Vincristine

2001
Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.
    Journal of neuro-oncology, 2001, Volume: 55, Issue:3

    Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem; Carboplatin; Carotid Arteries; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Etoposide; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Physical Examination; Rupture, Spontaneous; Temozolomide; Temporal Lobe; Vertebral Artery

2001
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine

2002
Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
    British journal of cancer, 2003, Jan-13, Volume: 88, Issue:1

    Topics: Animals; Antineoplastic Agents; Dacarbazine; Disease Models, Animal; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Male; Melanoma, Experimental; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Peptides, Cyclic; Somatostatin; Xenograft Model Antitumor Assays

2003
[Foliculitis in a patient with Hodkins disease].
    Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Dermatomycoses; Dexamethasone; Doxorubicin; Etoposide; Folliculitis; Hodgkin Disease; Humans; Itraconazole; Malassezia; Male; Melphalan; Opportunistic Infections; Vinblastine

2003
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
    The oncologist, 2003, Volume: 8, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Prognosis; Temozolomide; Treatment Outcome

2003
Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years.
    Acta oncologica (Stockholm, Sweden), 2003, Volume: 42, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gallium; Humans; Ifosfamide; Male; Middle Aged; Palliative Care; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vinblastine; Vincristine

2003
Chemotherapy for Hodgkin's disease.
    The New England journal of medicine, 2003, Sep-18, Volume: 349, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine

2003
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    International journal of radiation oncology, biology, physics, 2004, Mar-15, Volume: 58, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Germany; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2004
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
    Annals of hematology, 2004, Volume: 83, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine

2004
Long-term outcome of oligodendrogliomas.
    Neurology, 2004, May-25, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine

2004
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Mar-01, Volume: 23, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Failure; Vinblastine; Vincristine

2005
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
    Pediatric blood & cancer, 2006, Volume: 47, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dacarbazine; Etoposide; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Retrospective Studies; Survival Analysis; Temozolomide; Treatment Outcome

2006
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30

    Topics: Adolescent; Adult; Age Factors; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contraceptives, Oral; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Menstrual Cycle; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2005
Evolving approaches to primary treatment of Hodgkin lymphoma.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Neoplasm Staging; Prednisone; Procarbazine; Reed-Sternberg Cells; Stem Cell Transplantation; Vinblastine; Vincristine

2005
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Recurrence; Stem Cell Transplantation; Vinblastine; Vincristine

2005
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Child; Child, Preschool; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Gene Silencing; Glioblastoma; Humans; Kaplan-Meier Estimate; Neoplasm Proteins; Retrospective Studies; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins

2007
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Mediastinal Neoplasms; Positron-Emission Tomography; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine

2006
Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:2

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Etoposide; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Prospective Studies; Survivors; Ventricular Function, Left; Vinblastine; Vincristine

2006
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 2006, Sep-01, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Lung; Male; Mediastinum; Middle Aged; Prednisone; Procarbazine; Radiation Pneumonitis; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vinblastine; Vincristine

2006
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells.
    Cell death and differentiation, 2007, Volume: 14, Issue:3

    Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Death; Cell Line, Tumor; Dacarbazine; DNA Damage; Etoposide; Glioma; Humans; Membrane Proteins; Oxidation-Reduction; Phosphorylation; Temozolomide

2007
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
    Medicina, 2006, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Hodgkin Disease; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine

2006
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Consciousness Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Etoposide; Female; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pituitary Neoplasms; Temozolomide; Thiotepa; Topotecan

2008
[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nausea; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Remission Induction; Temozolomide; Young Adult

2006
[Our experiences in treating patients with Hodgkin disease in the last decade].
    Orvosi hetilap, 2007, Apr-15, Volume: 148, Issue:15

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Hungary; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2007
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:33

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymph Nodes; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vinblastine; Vincristine

2007
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
    Haematologica, 2008, Volume: 93, Issue:3

    Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Confusion; Cryoprotective Agents; Cytarabine; Dacarbazine; Dexamethasone; Dimethyl Sulfoxide; Doxorubicin; Etoposide; Hippocampus; Hodgkin Disease; Humans; Hyperventilation; Ifosfamide; Magnetic Resonance Imaging; Male; Melphalan; Paresthesia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Vinblastine; Vision Disorders

2008
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
    Voprosy onkologii, 2008, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Liver Neoplasms; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Radionuclide Imaging; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Vinblastine; Vincristine

2008
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fertility; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Middle Aged; Prednisone; Procarbazine; Semen; Spermatozoa; Testosterone; Vinblastine; Vincristine

2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
    British journal of cancer, 2008, Jul-22, Volume: 99, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Carboplatin; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Hepatocytes; Humans; Lomustine; Male; Membrane Glycoproteins; Middle Aged; Procarbazine; Recombinant Fusion Proteins; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine

2008
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
    Blood, 2009, Apr-02, Volume: 113, Issue:14

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Frequency; Glucuronosyltransferase; Hodgkin Disease; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Young Adult

2009
Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; DNA Methylation; Etoposide; Female; Glioma; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Nitrosourea Compounds; Retrospective Studies; Temozolomide; Treatment Outcome

2009
Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide.
    Cancer biology & therapy, 2009, Volume: 8, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Astrocytes; beta-Galactosidase; Cell Cycle; Cell Line, Tumor; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Damage; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Glioblastoma; Histones; Humans; Immunohistochemistry; Mutation; O(6)-Methylguanine-DNA Methyltransferase; Phosphorylation; Temozolomide; Time Factors; Tumor Suppressor Protein p53

2009
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Anticancer research, 2009, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult

2009
Efficacy of temozolomide treatment in patients with high-grade glioma.
    Anticancer research, 2009, Volume: 29, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Etoposide; Female; Glioblastoma; Gliosarcoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Tumor Necrosis Factor-alpha

2009
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine

2009
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Humans; Hyperthermia, Induced; Ifosfamide; Neoplasm Proteins; Oncogene Proteins, Fusion; Pleural Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Synovial; Tomography, X-Ray Computed; Vincristine

2010
Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Etoposide; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Meninges; Methotrexate; Myelitis; Neoplasm Invasiveness; Puberty; Radiation Injuries; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Spinal Cord; Spinal Neoplasms; Vincristine

2009
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine

2010
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.
    Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

2009
[Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2009, Volume: 11, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dacarbazine; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Retrospective Studies; Vincristine

2009
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
    Journal of the National Cancer Institute, 2010, Jun-16, Volume: 102, Issue:12

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2010
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Aug-10, Volume: 28, Issue:23

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Treatment Outcome; Vincristine

2010
Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vinblastine

2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3

    Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2011
Sorafenib enhances the in vitro anti-endothelial effects of low dose (metronomic) chemotherapy.
    Oncology reports, 2010, Volume: 24, Issue:4

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Administration Schedule; Endothelial Cells; Etoposide; Humans; In Vitro Techniques; Neovascularization, Pathologic; Niacinamide; Paclitaxel; Phenylurea Compounds; Pyridines; Sorafenib; Temozolomide

2010
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Anticancer research, 2010, Volume: 30, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult

2010
[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity].
    Voprosy onkologii, 2010, Volume: 56, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Dacarbazine; Discriminant Analysis; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Models, Statistical; Prognosis; Risk Factors; Vinblastine

2010
Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Humans; Methylprednisolone Hemisuccinate; Neuroectodermal Tumors, Primitive; Neuroprotective Agents; Radiotherapy; Spinal Neoplasms; Temozolomide; Thiotepa; Thoracic Vertebrae; Vincristine; Young Adult

2011
Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.
    Cancer, 2011, Oct-15, Volume: 117, Issue:20

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Promoter Regions, Genetic; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins

2011
Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.
    Anti-cancer drugs, 2011, Volume: 22, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Blotting, Western; Cell Line, Tumor; Central Nervous System Neoplasms; Cisplatin; Dacarbazine; Doxorubicin; Drug Synergism; Etoposide; Glioblastoma; Histone Deacetylase Inhibitors; Histones; Humans; Microtubules; Pyridines; Temozolomide

2011
Hodgkin's lymphoma--the great teacher.
    The New England journal of medicine, 2011, Jul-21, Volume: 365, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Salvage Therapy; Vinblastine; Vincristine

2011
Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
    Oncology, 2011, Volume: 80, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Dacarbazine; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Ifosfamide; Male; Middle Aged; Recurrence; Retrospective Studies; Temozolomide; Treatment Failure

2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
    Nature reviews. Clinical oncology, 2011, Sep-06, Volume: 8, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2011
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
    Revue des maladies respiratoires, 2011, Volume: 28, Issue:7

    Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult

2011
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
    Nature reviews. Clinical oncology, 2011, Oct-04, Volume: 8, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2011
Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.
    Pigment cell & melanoma research, 2012, Volume: 25, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dacarbazine; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Knockdown Techniques; Humans; Melanoma; Microphthalmia-Associated Transcription Factor; Neoplasm Proteins; RNA-Binding Proteins; RNA, Small Interfering; Temozolomide; Vinblastine

2012
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
    International journal of radiation oncology, biology, physics, 2012, May-01, Volume: 83, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lung; Lung Transplantation; Male; Middle Aged; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Risk Assessment; Vinblastine; Young Adult

2012
Avastin: more questions than answers. . .
    Journal of neurosurgery, 2012, Volume: 116, Issue:2

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Chemoradiotherapy; Dacarbazine; Etoposide; Female; Glioblastoma; Glioma; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Supratentorial Neoplasms; Temozolomide

2012
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:7

    Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Logistic Models; Menopause; Menstrual Cycle; Middle Aged; Multivariate Analysis; Ovary; Prednisone; Pregnancy; Procarbazine; Randomized Controlled Trials as Topic; Survivors; Vinblastine; Vincristine; Young Adult

2012
Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience.
    Oncology, 2012, Volume: 82, Issue:5

    Topics: Administration, Metronomic; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Child, Preschool; Dacarbazine; Etoposide; Europe; Feasibility Studies; Female; Fenofibrate; Humans; Infant; Isotretinoin; Male; Neoplasms; Pyrazoles; Registries; Sulfonamides; Temozolomide; Vitamin D; Young Adult

2012
[First case in Spain of bacteremia by Methylobacterium thiocyanatum from Hickmann catheter in an immunosuppressed patient with Hodgkin's lymphoma].
    Medicina clinica, 2012, Dec-01, Volume: 139, Issue:13

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Biofilms; Bleomycin; Carmustine; Catheter-Related Infections; Central Venous Catheters; Cisplatin; Cross Infection; Cytarabine; Dacarbazine; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Etoposide; Female; Gemcitabine; Gram-Negative Bacterial Infections; Hodgkin Disease; Humans; Immunocompromised Host; Melphalan; Methylobacterium; Prednisone; Ribotyping; Spain; Vinblastine

2012
[The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine

2012
[Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine

2012
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
    Voprosy onkologii, 2012, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine

2012
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
    Chinese journal of cancer, 2012, Volume: 31, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult

2012
[Relapse in Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Treatment Outcome; Vinblastine; Vincristine

2012
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult

2013
Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.
    European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:18

    Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Sarcoma, Synovial; Treatment Outcome

2012
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
    Journal of complementary & integrative medicine, 2012, Aug-10, Volume: 9

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide

2012
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.
    Bone marrow transplantation, 2013, Volume: 48, Issue:5

    Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Neuroblastoma; Outpatients; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Temozolomide

2013
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jan-10, Volume: 31, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Fertility Preservation; Follicle Stimulating Hormone; Germany; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Inhibins; Male; Menstrual Cycle; Middle Aged; Oligospermia; Ovary; Prednisone; Pregnancy; Procarbazine; Randomized Controlled Trials as Topic; Survivors; Testis; Testosterone; Vinblastine; Vincristine; Young Adult

2013
Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death.
    Current topics in medicinal chemistry, 2012, Volume: 12, Issue:19

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cnidarian Venoms; Dacarbazine; Drug Synergism; Etoposide; Glioblastoma; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Temozolomide

2012
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Retrospective Studies; Sperm Count; Testis; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult

2013
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    American journal of clinical oncology, 2015, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult

2015
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2013, Volume: 29, Issue:7

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult

2013
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine

2012
[Treatment of advanced Hodgkin lymphoma].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:23

    Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cause of Death; Climacteric; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Immunoconjugates; Molecular Targeted Therapy; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine

2013
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
    Voprosy onkologii, 2013, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2013
Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.
    Anticancer research, 2013, Volume: 33, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Immunoconjugates; Middle Aged; Multimodal Imaging; Prednisone; Procarbazine; Vinblastine; Vincristine

2013
Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
    Neurologia medico-chirurgica, 2013, Volume: 53, Issue:11

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Interferons; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome

2013
Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury.
    Acta oncologica (Stockholm, Sweden), 2014, Volume: 53, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Chemoradiotherapy; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Lung Injury; Middle Aged; Prednisone; Radiation Pneumonitis; Retrospective Studies; ROC Curve; Vinblastine; Young Adult

2014
Treatment of Hodgkin lymphoma: a 50-year perspective.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jan-20, Volume: 32, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Europe; History, 20th Century; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2014
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Neoplasm Staging; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Remission Induction; Stevens-Johnson Syndrome; Vinblastine; Vincristine; Young Adult

2014
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    British journal of haematology, 2014, Volume: 165, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2014
Which Hodgkin's patients in the Unites States should be treated with BEACOPP?
    Current hematologic malignancy reports, 2014, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Prednisone; Procarbazine; United States; Vinblastine; Vincristine

2014
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.
    Cancer biology & therapy, 2014, Volume: 15, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dacarbazine; Etoposide; Female; Heterografts; Humans; Immunoglobulin G; Lung Neoplasms; Melanoma, Experimental; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Signal Transduction; Small Cell Lung Carcinoma

2014
Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP).
    Journal of translational medicine, 2014, Jun-25, Volume: 12

    Topics: Adult; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; BRCA2 Protein; Cell Cycle; Cell Line, Tumor; Child; Cyclin A2; Dacarbazine; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Enzyme Inhibitors; Etoposide; Haploinsufficiency; Histones; Homologous Recombination; Humans; Mutagens; Phosphorylation; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reproducibility of Results; Single-Cell Analysis; Temozolomide

2014
Risk of premature menopause after treatment for Hodgkin's lymphoma.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Child, Preschool; Cytarabine; Dacarbazine; Doxorubicin; England; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Melphalan; Menopause, Premature; Ovary; Poisson Distribution; Proportional Hazards Models; Radiotherapy Dosage; Risk Assessment; Surveys and Questionnaires; Vinblastine; Wales; Young Adult

2014
Anticancer potential and mechanism of action of mango ginger (Curcuma amada Roxb.) supercritical CO₂ extract in human glioblastoma cells.
    Journal of evidence-based complementary & alternative medicine, 2015, Volume: 20, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbon Dioxide; Cell Line, Tumor; Cell Survival; Curcuma; Dacarbazine; Etoposide; Glioblastoma; Humans; Mice; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Temozolomide

2015
Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2015, Volume: 31, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniospinal Irradiation; Dacarbazine; Disease-Free Survival; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vinblastine; Young Adult

2015
The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.
    Anticancer research, 2015, Volume: 35, Issue:3

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Genes, p53; Glioma; Humans; Inhibitor of Apoptosis Proteins; Mutation; PTEN Phosphohydrolase; Silybin; Silymarin; Survivin; Temozolomide

2015
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vinblastine; Vincristine

2015
[Hodgkin's lymphoma and radiotherapy].
    Voprosy onkologii, 2015, Volume: 61, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2015
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
    Voprosy onkologii, 2015, Volume: 61, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2015
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
    British journal of haematology, 2015, Volume: 171, Issue:4

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Clinical Trials, Phase III as Topic; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Mechlorethamine; Multicenter Studies as Topic; Prednisone; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sample Size; Severity of Illness Index; Survival Analysis; Vinblastine; Vincristine

2015
Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma.
    European journal of ophthalmology, 2015, Dec-01, Volume: 26, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Combined Modality Therapy; Cryotherapy; Cyclophosphamide; Dacarbazine; Endotamponade; Etoposide; Humans; Infant; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Silicone Oils; Therapeutic Irrigation; Vincristine; Visual Acuity; Vitrectomy; Vitreous Hemorrhage

2015
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dacarbazine; Dactinomycin; Doxorubicin; Drug Synergism; Etoposide; G2 Phase Cell Cycle Checkpoints; Humans; Ifosfamide; Metabolic Networks and Pathways; Mitochondria; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Sarcoma, Ewing; Temozolomide; Vincristine

2015
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
    Acta haematologica, 2016, Volume: 135, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2016
Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
    Journal of assisted reproduction and genetics, 2016, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Fertility Preservation; Follow-Up Studies; Hodgkin Disease; Humans; Infertility, Female; Infertility, Male; Male; Pregnancy; Procarbazine; Surveys and Questionnaires; Vinblastine; Vincristine; Young Adult

2016
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Human reproduction (Oxford, England), 2016, Volume: 31, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Infertility, Male; Longitudinal Studies; Male; Prednisone; Procarbazine; Retrospective Studies; Semen Analysis; Spermatogenesis; Spermatozoa; Vinblastine; Vincristine

2016
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
    Asian Pacific journal of cancer prevention : APJCP, 2016, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Developed Countries; Doxorubicin; Etoposide; Female; Hodgkin Disease; Hospitals; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult

2016
Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor.
    Genes to cells : devoted to molecular & cellular mechanisms, 2016, Volume: 21, Issue:8

    Topics: Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Damage; DNA Repair; Etoposide; Humans; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Radiation, Ionizing; Recombinational DNA Repair; Sarcoma, Synovial; Temozolomide; Topoisomerase II Inhibitors

2016
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jan-15, Volume: 23, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Genomics; Humans; Indoles; Mice; Nuclear Proteins; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Small Cell Lung Carcinoma; Temozolomide; Xenograft Model Antitumor Assays

2017
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 10-10, Volume: 34, Issue:29

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Procarbazine; Vinblastine; Vincristine

2016
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cytarabine; Dacarbazine; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Iodobenzenes; Leukemia, Myeloid, Acute; Male; Paraganglioma; Radiation Tolerance; Temozolomide

2017
The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Turkish neurosurgery, 2018, Volume: 28, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Dacarbazine; DNA Damage; Drug Synergism; Etoposide; Glioblastoma; Humans; Temozolomide

2018
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
    Cancer, 2018, 01-01, Volume: 124, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mediastinal Neoplasms; Neoplasm Staging; Prednisone; Radiotherapy; Retrospective Studies; Survival Rate; Treatment Outcome; United States; Vinblastine; Vincristine; Young Adult

2018
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2018, Volume: 194, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cohort Studies; Dacarbazine; Etoposide; Female; Glioma; Humans; Ifosfamide; Leukopenia; Male; Neoplasm Grading; Prospective Studies; Temozolomide; Treatment Outcome; Vincristine

2018
Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant.
    Annals of hematology, 2018, Volume: 97, Issue:7

    Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Kaplan-Meier Estimate; Male; Melphalan; Methylprednisolone; Middle Aged; Proportional Hazards Models; Remission Induction; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Young Adult

2018
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
    Cellular oncology (Dordrecht), 2018, Volume: 41, Issue:3

    Topics: AC133 Antigen; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; RNA, Messenger; Temozolomide; Tumor Hypoxia; Vascular Endothelial Growth Factors

2018
Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Heart; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organs at Risk; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Vinblastine; Young Adult

2018
Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Staging; Pakistan; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tertiary Care Centers; Treatment Outcome; Vinblastine; Vincristine

2019
Heart on the wrong side.
    Australian journal of general practice, 2019, Volume: 48, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Dyspnea; Etoposide; Hematuria; Hepatomegaly; Hodgkin Disease; Humans; Lower Urinary Tract Symptoms; Lymphadenopathy; Male; Marfan Syndrome; Mediastinum; Neoplasm Staging; Pectus Carinatum; Pleural Effusion; Prednisone; Procarbazine; Splenomegaly; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult

2019
What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin's Lymphoma: To Irradiate or Not to Irradiate?
    International journal of radiation oncology, biology, physics, 2020, 01-01, Volume: 106, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2020
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Organs at Risk; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Retrospective Studies; Treatment Outcome; Tunisia; Vinblastine; Vincristine; Young Adult

2020
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
    British journal of haematology, 2020, Volume: 190, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxychloroquine; Idarubicin; Mediastinal Neoplasms; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Prednisone; Procarbazine; SARS-CoV-2; Treatment Outcome; Vinblastine; Vincristine

2020
Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vinblastine

2020
Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
    Annals of hematology, 2020, Volume: 99, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome; Vinblastine; Young Adult

2020
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 01-10, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Progression-Free Survival; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2021
Evaluation of ovarian reserve before and after chemotherapy.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult

2021
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
    Annals of hematology, 2021, Volume: 100, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; England; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2021
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
    International journal of laboratory hematology, 2022, Volume: 44, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine

2022
Sequencing therapies in Hodgkin lymphoma.
    The Lancet. Haematology, 2021, Volume: 8, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carboplatin; Dacarbazine; Disease Management; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Vinblastine

2021
Bleomycin-induced Pneumonitis in a Child Treated With Nintedanib: Report of the First Case in a Childhood.
    Journal of pediatric hematology/oncology, 2022, Mar-01, Volume: 44, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Male; Pneumonia; Prednisone; Vinblastine; Vincristine

2022
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Vinblastine; Vincristine

2023
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
    Journal of pharmaceutical and biomedical analysis, 2022, Nov-30, Volume: 221

    Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water

2022
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
    International journal of cancer, 2023, 08-15, Volume: 153, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; Dacarbazine; Denmark; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Reproduction; Sweden; Vinblastine; Vincristine

2023
Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource-limited country: An observational study.
    Cancer reports (Hoboken, N.J.), 2023, Volume: 6, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Retrospective Studies; Survival Rate; Thailand; Vinblastine; Vincristine

2023